share_log

Exicure | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Exicure | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Exicure | PRE 14A：並購重組委托聲明
美股sec公告 ·  07/19 16:16
Moomoo AI 已提取核心訊息
Exicure, Inc., a biotechnology company based in Chicago, Illinois, has announced a Special Meeting of Stockholders to be held virtually on August 15, 2024. The primary agenda for the meeting is to seek approval for an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock. The proposed reverse stock split ratio ranges from 1-for-2 to 1-for-15, with the exact ratio to be determined at the discretion of the Board of Directors. The reverse stock split is intended to comply with Nasdaq's minimum bid price requirement, as the company's stock price has previously fallen below the $1.00 threshold. Exicure received a notice from Nasdaq on September 13, 2023, regarding non-compliance with...Show More
Exicure, Inc., a biotechnology company based in Chicago, Illinois, has announced a Special Meeting of Stockholders to be held virtually on August 15, 2024. The primary agenda for the meeting is to seek approval for an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock. The proposed reverse stock split ratio ranges from 1-for-2 to 1-for-15, with the exact ratio to be determined at the discretion of the Board of Directors. The reverse stock split is intended to comply with Nasdaq's minimum bid price requirement, as the company's stock price has previously fallen below the $1.00 threshold. Exicure received a notice from Nasdaq on September 13, 2023, regarding non-compliance with the minimum bid price requirement and was given until September 9, 2024, to regain compliance. The company believes that the reverse stock split will improve the marketability and liquidity of its common stock. Stockholders of record as of July 26, 2024, will be entitled to vote at the Special Meeting. The company has also provided information on how stockholders can attend the virtual meeting and cast their votes.
總部位於伊利諾伊州芝加哥的生物技術公司Exicure，宣佈將於2024年8月15日虛擬舉行特別股東大會。會議的主要議程是尋求批准修訂公司的修正公司章程以實現其普通股的股票拆分。建議的普通股拆分比例範圍爲1股拆分爲2股至1股拆分爲15股，具體比例由董事會酌情決定。這次的普通股拆分旨在遵守納斯達克的最低買盤價格要求，因爲該公司股票價格曾低於1美元的門檻。Exicure在2023年9月13日收到了來自納斯達克的通知，稱未達到最低買盤價格要求，要求其在2024年9月9日之前恢復符合條件。該公司相信這次的股票拆分將改善其普通股的市場營銷和流動性。2024年7月26日作爲股東記錄日的股東將有權參加特別股東大會並投票。公司還提供了有關股東如何參加虛擬會議並投票的信息。
總部位於伊利諾伊州芝加哥的生物技術公司Exicure，宣佈將於2024年8月15日虛擬舉行特別股東大會。會議的主要議程是尋求批准修訂公司的修正公司章程以實現其普通股的股票拆分。建議的普通股拆分比例範圍爲1股拆分爲2股至1股拆分爲15股，具體比例由董事會酌情決定。這次的普通股拆分旨在遵守納斯達克的最低買盤價格要求，因爲該公司股票價格曾低於1美元的門檻。Exicure在2023年9月13日收到了來自納斯達克的通知，稱未達到最低買盤價格要求，要求其在2024年9月9日之前恢復符合條件。該公司相信這次的股票拆分將改善其普通股的市場營銷和流動性。2024年7月26日作爲股東記錄日的股東將有權參加特別股東大會並投票。公司還提供了有關股東如何參加虛擬會議並投票的信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息